Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

Cross-sectional surveys of measles antibodies in the Jiangsu Province of China from 2008 to 2010: the effect of high coverage with two doses of measles vaccine among children.

Liu Y, Lu P, Hu Y, Wang Z, Deng X, Ma F, Tao H, Jia C, Ding X, Yang H, Liu P, Min J.

PLoS One. 2013 Jun 25;8(6):e66771. doi: 10.1371/journal.pone.0066771. Print 2013.

2.

Sero-epidemiology of measles in general population in Jiangsu province of China: application of mixture models to interpret the results from a cross-sectional study.

Liu Y, Tao H, Ma F, Lu P, Hu Y, Ding X, Liu P, Min J, Li J, Sun J, Xiao S.

Vaccine. 2011 Jan 29;29(5):1000-4. doi: 10.1016/j.vaccine.2010.11.081. Epub 2010 Dec 14.

PMID:
21163248
3.

[Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].

Zäch K, Nicoara C, Germann D, Matter L.

Schweiz Med Wochenschr. 1998 Apr 25;128(17):649-57. German.

PMID:
9622837
4.

Waning immunity to measles in young adults and booster effects of revaccination in secondary school students.

He H, Chen EF, Li Q, Wang Z, Yan R, Fu J, Pan J.

Vaccine. 2013 Jan 7;31(3):533-7. doi: 10.1016/j.vaccine.2012.11.014. Epub 2012 Nov 14.

PMID:
23159458
5.

Measles IgG seroprevalence prior to mass vaccination in Taiwan.

Lee MS, Nokes DJ, Wu YC, Huang YH, Lu CF.

Int J Infect Dis. 2002 Mar;6(1):42-7.

PMID:
12044301
6.

Population immunity to measles in the United States, 1999.

Hutchins SS, Bellini WJ, Coronado V, Jiles R, Wooten K, Deladisma A.

J Infect Dis. 2004 May 1;189 Suppl 1:S91-7. Review.

PMID:
15106096
7.

Analysis of the cause of increased measles incidence in Xinjiang, China in 2004.

Yu X, Wang S, Guan J, Mahemuti, Purhati, Gou A, Liu Q, Jin X, Ghildyal R.

Pediatr Infect Dis J. 2007 Jun;26(6):513-8.

PMID:
17529869
8.

Seroepidemiology of mumps in the general population of Jiangsu province, China after introduction of a one-dose measles-mumps-rubella vaccine.

Liu Y, Hu Y, Deng X, Wang Z, Lu P, Ma F, Zhou M, Liu P, Min J.

Sci Rep. 2015 Oct 1;5:14660. doi: 10.1038/srep14660.

9.
10.

Measles antibody prevalence rates among young adults in Israel.

Gdalevich M, Robin G, Mimouni D, Grotto I, Shpilberg O, Ashkenazi I.

Am J Infect Control. 2002 May;30(3):165-9.

PMID:
11988711
11.

The 2001 serological survey in the Czech Republic--measles.

Mrázová M, Svandová E, Smelhausová M, Sestáková Z, Benes C.

Cent Eur J Public Health. 2003 Dec;11 Suppl:S36-41.

PMID:
15080258
12.

Pattern of susceptibility to measles in Italy. Serological Study Group.

Salmaso S, Gabutti G, Rota MC, Giordano C, Penna C, Mandolini D, Crovari P.

Bull World Health Organ. 2000;78(8):950-5.

13.

Measles seroepidemiology and decay rate of vaccine-induced measles IgG titers in Taiwan, 1995-1997.

Lee MS, Chien LJ, Yueh YY, Lu CF.

Vaccine. 2001 Sep 14;19(32):4644-51.

PMID:
11535312
14.

EPI vaccines-induced antibody prevalence in 8-9 year-olds in The Gambia.

Viviani S, Mendy M, Jack AD, Hall AJ, Montesano R, Whittle HC.

Trop Med Int Health. 2004 Oct;9(10):1044-9.

15.

Age-related changes in serological susceptibility patterns to measles: results from a seroepidemiological study in Dongguan, China.

Xiong Y, Wang D, Lin W, Tang H, Chen S, Ni J.

Hum Vaccin Immunother. 2014;10(4):1097-03. Epub 2014 Jan 21.

16.
17.

Antibody persistence after primary measles-mumps-rubella vaccine and response to a second dose given at four to six vs. eleven to thirteen years.

Johnson CE, Kumar ML, Whitwell JK, Staehle BO, Rome LP, Dinakar C, Hurni W, Nalin DR.

Pediatr Infect Dis J. 1996 Aug;15(8):687-92.

PMID:
8858673
19.

Seroprevalence of neutralizing antibodies to measles virus in a vaccinated population in Iran, 1998.

Loo MK, Sabahi F, Soleimanjdahi H, Kazemnejad A, Roustai MH.

Eur J Epidemiol. 2003;18(11):1085-9.

PMID:
14620944
20.

Assessment of measles immunity among infants in Maputo City, Mozambique.

Jani JV, Holm-Hansen C, Mussá T, Zango A, Manhiça I, Bjune G, Jani IV.

BMC Public Health. 2008 Nov 12;8:386. doi: 10.1186/1471-2458-8-386.

Supplemental Content

Support Center